Found 7 matching trials
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
PHASE3This is a phase III multi-centre study in three periods: the first period i...
Location
Multiple Locations
A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
PHASE3This study consists of a 4 week run-in period with a Ca based phosphate bin...
Location
Multiple Locations
A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
PHASE3This is a phase III multi-centre study in two periods: the first period is ...
Location
Multiple Locations
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
PHASE3This is a phase III multi-centre study in three periods: the first period i...
Location
Multiple Locations
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
PHASE3The primary objective of this study is to demonstrate the superiority of MC...
Location
Multiple Locations
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
PHASE3The primary objective of this study is to demonstrate the long-term safety ...
Location
Multiple Locations
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
PHASE3This is a PIII multi-center, open-label, flexible dose, long-term safety st...
Location
Multiple Locations